Cannabis Report
Home > Boards > US Listed > Biotechs > NanoViricides Inc. (NNVC)

As if they never mentioned many of their

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Its_lose_not_loose Member Profile
Member Level 
Followed By 8
Posts 5,343
Boards Moderated 0
Alias Born 09/11/13
160x600 placeholder
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 9/12/2018 6:05:23 AM
NanoViricides Inc. to Present at 20th Annual Rodman & Renshaw Conference in NYC on Sept 6th PR Newswire (US) - 9/5/2018 7:00:00 AM
NanoViricides Reports Its Topical Dermal Shingles Candidates Effective in Reducing Pain in Animal Study PR Newswire (US) - 8/7/2018 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/23/2018 4:44:51 PM
NanoViricides, Inc. Welcomes Dr. Irach Taraporewala as the New CEO PR Newswire (US) - 7/23/2018 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/19/2018 6:04:09 AM
NanoViricides Provides Update on Recent Events PR Newswire (US) - 7/12/2018 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 7/11/2018 6:05:20 AM
Progress of NanoViricides' Shingles Drug Program Presented at the 31st International Conference on Antiviral Research PR Newswire (US) - 6/26/2018 7:00:00 AM
NanoViricides Files Quarterly Report for Period Ending March 31, 2018; Company Has Over A Year's Worth of Cash in Hand, and I... PR Newswire (US) - 5/22/2018 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/21/2018 4:22:22 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 5/15/2018 4:33:34 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/4/2018 6:07:03 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/4/2018 5:11:56 PM
NanoViricides Reports Good Safety Profile of Topical Dermal Drug Candidates; Dr. Diwan, President, Will Present at the MicroC... PR Newswire (US) - 4/9/2018 7:00:00 AM
NanoViricides Drug Candidates to be Tested in Animal Models of Dermal, Ocular and Genital Herpes Virus Infection at the Unive... PR Newswire (US) - 3/19/2018 11:12:00 AM
NanoViricides Files Quarterly Report for Period Ending December 31, 2017 PR Newswire (US) - 2/21/2018 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/20/2018 1:55:19 PM
Notification That Quarterly Report Will Be Submitted Late (nt 10-q) Edgar (US Regulatory) - 2/14/2018 5:57:04 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/15/2017 10:29:10 AM
Nanoviricides Initiates a Safety/Toxicology Study of Its Leading Shingles Candidates PR Newswire (US) - 12/6/2017 7:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 11/22/2017 4:23:23 PM
NanoViricides Files Quarterly Report for Period Ending September 30, 2017 PR Newswire (US) - 11/20/2017 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2017 5:25:18 PM
Revised Proxy Soliciting Materials (definitive) (defr14a) Edgar (US Regulatory) - 11/8/2017 5:18:02 PM
Its_lose_not_loose Member Level  Friday, 11/10/17 07:02:16 PM
Re: leifsmith post# 135939
Post # of 140769 
As if they never mentioned many of their countless other failures or misrepresentations.

It would be dangerous to invest in NNVC at this juncture.


"Who would claim to be one who was not?"
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist